Study of Circadian Melatonin Secretion Pattern at Different Stages of Parkinson's Disease

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical neuropharmacology

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00002826-200303000-00005PMID 12671525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of dim light on suppression of nocturnal melatonin in healthy women and men

  2005cited by this paper
• Pharmacological modifications in dopaminergic neurotransmission affect the quinpirole-evoked suppression of serotonin N-acetyltransferase activity in chick retina: an impact on dopamine D4-like receptors

  2005cited by this paper
• The role of deep brain stimulation as a surgical treatment for Parkinson's disease.

  2000cited by this paper
• Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study.

  2000cited by this paper
• Melatonin‐induced withdrawal emergent dyskinesia and akathisia

  1999cited by this paper
• Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype.

  1999cited by this paper
• Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type.

  1999cited by this paper
• Melatonin administration increases the affinity of D2 dopamine receptors in the rat striatum.

  1998cited by this paper
• Melatonin and Biological Rhythms

  1998cited by this paper
• Oxidative damage in the central nervous system: protection by melatonin.

  1998cited by this paper
• Plasma melatonin and cortisol in patients with obsessive-compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms.

  1998cited by this paper
• Melatonin levels in Parkinson's disease: drug therapy versus electrical stimulation of the internal globus pallidus.

  1997cited by this paper
• Neurobiology of retinal dopamine in relation to degenerative states of the tissue.

  1997cited by this paper
• Melatonin, its receptors, and relationships with biological rhythm disorders.

  1997cited by this paper
• Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa.

  1997cited by this paper
• Modifications of circadian and circannual rhythms with aging.

  1997cited by this paper
• Management of motor fluctuations in Parkinson's disease.

  1996cited by this paper
• Effects of daily injections of melatonin on locomotor activity rhythms in rats maintained under constant bright or dim light.

  1996cited by this paper
• Melatonin‐dopamine interaction in the striatal projection area of sensorimotor cortex in the rat

  1996cited by this paper
• Functional interaction of melatonin receptors and D1 dopamine receptors in cultured chick retinal neurons

  1995cited by this paper
• Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism.

  1995cited by this paper
• Neurochemical organization of circadian rhythm in the suprachiasmatic nucleus.

  1994cited by this paper
• Basic mechanisms of motor fluctuations.

  1994cited by this paper
• The role of dopamine in the regulation of melatonin biosynthesis in vertebrate retina.

  1994cited by this paper
• Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats

  1994cited by this paper
• Melatonin reduces dopamine content in the neurointermediate lobe of male Syrian hamsters.

  1993cited by this paper
• Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase-shifting properties of l-dopa

  1993cited by this paper
• Quantitative assessment of parkinsonian patients by continuous wrist activity monitoring.

  1993cited by this paper
• Melatonin and sleep in humans

  1993cited by this paper
• Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease

  1993cited by this paper
• Circadian secretion pattern of melatonin in Parkinson's disease

  1991cited by this paper
• Fatigue and melatonin in Parkinson's disease.

  1991cited by this paper
• Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice.

  1990cited by this paper
• Circadian fluctuations of contrast sensitivity in Parkinson's disease

  1990cited by this paper
• Catecholamine receptors regulating serotonin N-acetyltransferase activity and melatonin content of chicken retina and pineal gland: D2-dopamine receptors in retina and alpha-2 adrenergic receptors in pineal gland.

  1989cited by this paper
• Locus coeruleus-pineal melatonin interactions and the pathogenesis of the "on-off" phenomenon associated with mood changes and sensory symptoms in Parkinson's disease.

  1989cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Motor fluctuations in Parkinson's disease: Pathogenetic and therapeutic studies

  1987cited by this paper
• Effect of apomorphine on melatonin secretion in normal subjects

  1987cited by this paper
• Characteristics of circadian rhythms in human functions.

  1986cited by this paper
• Methods for cosinor-rhythmometry.

  1979cited by this paper
• Melatonin and Abnormal Movements Induced by L-Dopa in Mice

  1971cited by this paper

• More Than Rapid Eye Movement Sleep Behavior Disorder: Sleep Differences in Parkinson’s Disease LRRK2 and GBA Genotypes

  2025influential citation
• Dysregulation of melatonin rhythm in Parkinson’s and Huntington’s disease: a systematic review and meta-analysis

  2025cites this paper
• A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease

  2025cites this paper
• Circadian attributes of neurological and psychiatric disorders as basis for their medication chronotherapy.

  2025cites this paper
• The Intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders.

  2025cites this paper
• The Use of Melatoninergic Antidepressants for Stabilization of Remission in Depression Comorbid with Alcohol Abuse, Anxiety or Neuropsychiatric Disorders: A Systematic Review

  2024cites this paper
• Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial

  2024cites this paper
• Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease

  2024cites this paper
• Circadian Intervention Improves Parkinson’s Disease and May Slow Disease Progression: A Ten Year Retrospective Study

  2024cites this paper
• Intersection of Sleep Disorders and Parkinson Disease: Unveiling the Bidirectional Relationship

  2024cites this paper
• Blunted Melatonin Circadian Rhythm in Parkinson’s Disease: Express Bewilderment

  2024cites this paper
• Metabolic Basis of Circadian Dysfunction in Parkinson’s Disease

  2023cites this paper
• Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials

  2023cites this paper
• Molecular mechanisms of melatonin-induced alleviation of synaptic dysfunction and neuroinflammation in Parkinson's disease: a review.

  2023cites this paper
• Circadian disruption and sleep disorders in neurodegeneration

  2023cites this paper
• Parkinson’s Disease: A Narrative Review on Potential Molecular Mechanisms of Sleep Disturbances, REM Behavior Disorder, and Melatonin

  2023cites this paper
• Chronodisruption and Loss of Melatonin Rhythm, Associated with Alterations in Daily Motor Activity and Mitochondrial Dynamics in Parkinsonian Zebrafish, Are Corrected by Melatonin Treatment

  2023cites this paper
• Circadian profile, daytime activity, and the Parkinson's phenotype: A motion sensor pilot study with neurobiological underpinnings.

  2023cites this paper
• Neurological Insights into Sleep Disorders in Parkinson’s Disease

  2023cites this paper
• The multimodal effect of circadian interventions in Parkinson's disease: A narrative review.

  2023cites this paper
• Predicting neurodegeneration from sleep related biofluid changes.

  2023cites this paper
• Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease

  2023cites this paper
• Circadian Rhythms in Parkinson’s Disease

  2022cites this paper
• The prevalence of sleep loss and sleep disorders in young and old adults

  2022cites this paper
• Melatonin Treatment for Sleep Disorders in Parkinson's Disease: A Meta-Analysis and Systematic Review

  2022cites this paper
• Sleep and circadian rhythms in Parkinson’s disease and preclinical models

  2022cites this paper
• Influence of sleep disruption on protein accumulation in neurodegenerative diseases

  2022cites this paper
• Etiologies of insomnia in Parkinson's disease - Lessons from human studies and animal models.

  2022cites this paper
• Chronobiology of Parkinson's disease: Past, present and future

  2022cites this paper
• Circadian Rhythm Sleep-Wake Disorders in Older Adults.

  2022cites this paper
• Short histological kaleidoscope – recent findings in histology. Part I

  2022cites this paper
• A Pilot Randomized Controlled Trial Investigating MBSR for Parkinson’s Disease Patients and Their Caregiving Partners: Effects on Distress, Social support, Cortisol, and Inflammation

  2022cites this paper
• Roles of clock genes in the pathogenesis of Parkinson's disease.

  2021cites this paper
• A Computational Analysis in a Cohort of Parkinson’s Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes

  2021cites this paper
• Circadian rhythms in neurodegenerative disorders

  2021cites this paper
• Melatonin as first‐line treatment for sleep disorders in Parkinson's disease?

  2021cites this paper
• The Relationship between Amyotrophic Lateral Sclerosis and Parkinson’s Disease and Sleep Disorders: Pathophysiological and Clinical Approach

  2021cites this paper
• Peripheral Clock System Abnormalities in Patients With Parkinson’s Disease

  2021cites this paper
• Defining circadian disruption in neurodegenerative disorders.

  2021cites this paper
• Melatonin as a Reducer of Neuro- and Vasculotoxic Oxidative Stress Induced by Homocysteine

  2021cites this paper
• Circadian activity rhythm in Parkinson's disease: findings from the PHASE study.

  2021cites this paper
• The circadian system in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

  2021cites this paper
• Sleep Disturbance, Sleep Disorders and Co-Morbidities in the Care of the Older Person

  2021cites this paper
• Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease

  2021cites this paper
• Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats

  2021cites this paper
• Sleep Neurology: A Comprehensive Guide to Basic and Clinical Aspects

  2021cites this paper
• Melatonin secretion in patients with Parkinson's disease receiving different-dose levodopa therapy.

  2020cites this paper
• Disorders of Sleep and Wakefulness in Parkinson’s Disease and Other Movement Disorders

  2020cites this paper
• Circadian Rhythms Disruption

  2020cites this paper
• Association between circadian disruption and diseases: A narrative review.

  2020cites this paper
• Diurnal patterns and circadian aspects of Parkinson's disease: retinal, hypothalamic/midbrain, and pineal participation

  2020cites this paper
• Bright light improves sleep in patients with Parkinson’s disease: possible role of circadian restoration

  2020cites this paper
• Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: A randomized, double-blind, placebo-controlled trial.

  2020cites this paper
• Circadian rhythm abnormalities

  2020cites this paper
• Circadian disruption and human health: A bidirectional relationship

  2020cites this paper
• Sleep Disorders in Parkinson’s Disease: Management and Case Study

  2020cites this paper
• Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases

  2020cites this paper
• Circadian Clocks Function in Concert with Heat Shock Organizing Protein to Modulate Mutant Huntingtin Aggregation and Toxicity

  2019cites this paper
• Physiology of the Pineal Gland and Melatonin

  2019cites this paper
• Therapeutic implications of circadian clocks in neurodegenerative diseases

  2019cites this paper
• Pathophysiological mechanisms of non-motor features and their role on the pathogenic process in Parkinson's disease

  2019cites this paper
• An Overview of the Effects of Melatonin on Nervous System Diseases

  2019cites this paper
• Sleep as a Therapeutic Target in the Aging Brain

  2019cites this paper
• Melatonin: Clinical Perspectives in Neurodegeneration

  2019cites this paper
• Circadian Rhythms: Implications for Health and Disease.

  2019cites this paper
• Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's disease.

  2019cites this paper
• Chronotherapies for Parkinson's disease.

  2019cites this paper
• Association between circadian rhythms and neurodegenerative diseases.

  2019cites this paper
• An overview of sleep and circadian dysfunction in Parkinson's disease

  2018influential citation
• Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson’s disease: a systematic review

  2018cites this paper
• The effect of light exposure on insomnia and nocturnal movement in Parkinson's disease: an open label, retrospective, longitudinal study.

  2018cites this paper
• Connection between circadian rhythms and neurodegenerative diseases

  2018cites this paper
• Effect of stimulation of mRGCs on Alzheimer’s and Parkinson’s disease

  2018cites this paper
• Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease

  2018cites this paper
• Polychromatic Light Exposure as a Therapeutic in the Treatment and Management of Parkinson's Disease: A Controlled Exploratory Trial

  2018cites this paper
• Melatonin receptors: distribution in mammalian brain and their respective putative functions

  2017cites this paper
• Sleep and Neurodegeneration: A Critical Appraisal.

  2017cites this paper
• Multifactorial sleep disturbance in Parkinson's disease.

  2017cites this paper
• Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders.

  2017cites this paper
• Alterations of the circadian system in Parkinson's disease patients

  2017influential citation
• The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease

  2017cites this paper
• Sleepiness in the Elderly.

  2017cites this paper
• A New Perspective for Parkinson’s Disease: Circadian Rhythm

  2017cites this paper
• Long-term Levodopa Treatment Accelerates the Circadian Rhythm Dysfunction in a 6-hydroxydopamine Rat Model of Parkinson's Disease

  2017cites this paper
• Circadian Rhythm Sleep-Wake Disorders in Older Adults.

  2017cites this paper
• Chapter 39 – Circadian Dysregulation in Mental and Physical Health

  2017cites this paper
• Serum Levels of Melatonin and Sleep Evaluation Scales in the Diagnosis of Sleep Disorders in Patients with Idiopathic Parkinson's Disease.

  2017cites this paper
• [Heterogeneity of excessive daytime sleepiness in Parkinson's disease].

  2016cites this paper
• Loss of REM sleep features across nighttime in REM sleep behavior disorder.

  2016cites this paper
• A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson’s disease

  2016cites this paper
• "A GREAT PERTURBATION IN NATURE" : PARKINSON'S DISEASE AND SLEEP DISORDERS

  2016cites this paper
• The Relationship between Circadian Dysfunction and Cognitive Impairment in Individuals with Parkinson's Disease

  2016cites this paper
• Melatonin and cortisol profiles in late midlife and their association with age-related changes in cognition

  2016cites this paper
• Chronic sleep disturbance and neural injury: links to neurodegenerative disease

  2016cites this paper
• [Heterogeneity of excessive daytime sleepiness in Parkinson's disease].

  2016cites this paper
• Sleep-wake disturbances in the premotor and early stage of Parkinson's disease.

  2016cites this paper
• Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms

  2016cites this paper
• Circadian system — A novel diagnostic and therapeutic target in Parkinson's disease?

  2016cites this paper
• Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention

  2016cites this paper
• Neuroendocrine abnormalities in Parkinson's disease

  2016cites this paper